Innova Biosciences Secures Prestigious Development of Prototype Grant from the Technology Strategy Board
Innova Biosciences, inventor of 'Lightning-Link', the world’s easiest to use antibody labelling technology, is pleased to announce it has been awarded a development of prototype grant circa £210,000 by the Technology Strategy Board
View full press release